	ITO-based multi-band metasurface absorber for early detection of hepatic cancer through deep learning. Opt Express Farooq U, Asif Khan H, Murtaza F, Alathbah M, Yang L, Liu N. PMID: 42839429 [PubMed - indexed for MEDLINE]
	Highly sensitive detection of exosomal miR-122 with CRISPR-Dx for precise HCC diagnosis. Anal Chim Acta Xie C, Lv H, Wang Y, Abdukayum A, Li X, Wu P. PMID: 42838687 [PubMed - indexed for MEDLINE]
	Perfusion beyond Margin in Hepatocellular Carcinoma: A Contrast-enhanced US Feature Related to Tumor Invasiveness and Prognosis. Radiology Ding W, Ji R, Pang C, Li J, Liu F, Yu J, Liang P. PMID: 42836755 [PubMed - indexed for MEDLINE]
	Hepatocellular Carcinoma in the Eastern World: Screening, Diagnosis, Staging and Treatment. Curr Pharm Des Wu TH, Cheng CH, Wang YC, Hung HC, Lee JC, Lai Y, Wu TJ, Chou HS, Lee CF, Lee WC, Chan KM. PMID: 42836499 [PubMed - indexed for MEDLINE]
	Polymeric Nanomedicines for siRNA Delivery in Hepatocellular Carcinoma: Emerging Therapeutic Strategies, Combination Approaches, and Translational Perspectives. Int J Nanomedicine Thalij KM, You HW, Habeeb M, Ratchagar JV, Khot VS, Gorde PL. PMID: 42836161 [PubMed - indexed for MEDLINE]
	Optimal timing of surgery after conversion therapy for initially unresectable hepatocellular carcinoma: a multicenter study integrating major pathological response and treatment duration. Front Immunol Li S, Li M, Zhu F, Qin Y, Tang W, Yao J, Chen J, Liu L, Liang Z, Wei H, He Y, Wang G, Zhang J, Xiang B. PMID: 42835116 [PubMed - indexed for MEDLINE]
	Development and external validation of an interpretable deep learning model for early immune-related adverse events in hepatocellular carcinoma. Front Immunol Pan H, Zhao C, Sun H, Zhao H, Tang G, Du X, Xia T. PMID: 42835027 [PubMed - indexed for MEDLINE]
	Direct-Acting Antiviral Therapy in Patients With Hepatocellular Carcinoma Receiving Non-Curative Treatment: High Sustained Virological Response Rates and Preservation of Liver Functional Reserve. J Viral Hepat Sato S, Yamaguchi M, Nago H, Kato Y, Om R, Terai Y, Kita Y, Ikeda Y, Sato S, Murata A, Shimada Y, Genda T. PMID: 42834589 [PubMed - indexed for MEDLINE]
	Efficacy and Safety of First-Line Treatment Options for Oncogene Wild-Type Lung Adenocarcinoma With Liver Metastases. Cancer Med Li J, Ge Y, Liu Q, Wei X, Wang J, Wang X, Wang D, Liu J, Sun Y, Gao A. PMID: 42834503 [PubMed - indexed for MEDLINE]
	Multimodal radiopathomics model predicts postoperative metachronous liver metastasis in gastric cancer. Nat Commun Ding P, Yang J, Guo H, Chen S, Liu Y, Han X, Li S, Wu J, Yang L, Wu H, Meng N, Li X, Gu R, Tian Y, Zhang L, Guo Z, Lu L, Yang S, Meng L, Zhao Q. PMID: 42834048 [PubMed - indexed for MEDLINE]
	H19 and the PD-1/PD-L1 Axis in hepatocellular carcinoma and colorectal cancer: emerging evidence, mechanistic links, and therapeutic perspectives. Clin Exp Med Nami MT, EmamiPari F, Farrokhi N, Fattahyan I, Yekkalam M. PMID: 42831944 [PubMed - indexed for MEDLINE]
	Clinical Presentation and Surgical Management of Liver Hemangioma: A Single-center Retrospective-prospective Study of 101 Cases. Prague Med Rep Nikolaev E, Vylcheva M, Kostov D. PMID: 42831603 [PubMed - indexed for MEDLINE]
	Deep learning-based CNN method for fiducial marker detection in kilovoltage X-ray images for liver tumor motion monitoring. Med Phys Kan F, Jin F, Mylonas A, Zwan B, Nguyen T, Moodie T, Hardcastle N, Liu SF, Mason D, Wang T, Lee YY, Keall P, Sengupta C. PMID: 42830534 [PubMed - indexed for MEDLINE]
	Beyond Antibodies: Glypican-3-Targeting Peptides for Precision Hepatocellular Carcinoma Theranostics. J Pept Sci Nagpure NR, Tripathi NM, Verma N, Bandyopadhyay A. PMID: 42830470 [PubMed - indexed for MEDLINE]
	Fibrolamellar Carcinoma in the Molecular Era: From DNAJB1::PRKACA Biology to Precision Therapeutic Strategies. J Gastrointest Cancer Bayda, Ökten . PMID: 42828719 [PubMed - indexed for MEDLINE]
	Pattern-Based P53 Immunohistochemistry Predicts Recurrence in Colorectal Liver Metastases Without Complete Pathologic Response After Neoadjuvant Chemotherapy. Cancer Rep (Hoboken) Ho PTH, Nguyen DD, Hao VDT, Tran GH, Trung LV, Van Hoang T, Nguyen HB. PMID: 42827381 [PubMed - indexed for MEDLINE]
	Sex Differences in Mortality Among Patients With Hepatocellular Carcinoma. JAMA Netw Open Yan T, Yeh ML, Leong J, Toyoda H, Abe H, Jun DW, Roberts L, Tanaka Y, Schwartz M, Hsu YC, Landis C, Vutien P, Uojima H, Honda T, Buti M, Trinh H, Ogawa E, Yasuda S, Tseng CH, Maeda M, Sola E, Suzuki T, Huang CF, Tsai PC, Dai CY, Huang JF, Chuang WL, Cheung R, Yu ML, Nguyen MH. PMID: 42826017 [PubMed - indexed for MEDLINE]
	Interventional Management of Patients with Hepatocellular Carcinoma and Portal Vein Tumor Thrombosis: Are There Differences Between East and West? Curr Oncol Rep Yan R, Sun T, Lu J, Teng GJ. PMID: 42825963 [PubMed - indexed for MEDLINE]
	Metabolic dysfunction and GZMK(+) CD8(+) T-cell remodeling in hepatocellular carcinoma: an evidence-stratified, hypothesis-generating review. Front Immunol Zhong Q, Lyu W, Li J, Song Y, Huang Y, Wang C, Ji J. PMID: 42824776 [PubMed - indexed for MEDLINE]
	Immune escape in portal vein tumor thrombus: an intravascular tumor-immune niche framework for hepatocellular carcinoma. Front Immunol Li X, Ma D, Yuan Z, Zhu J, Gao J. PMID: 42819771 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 77716

Page 1 of 3886



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy